Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02576977 |
|---|---|
| Brief Title: | Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183) |
| First Submitted : | October 14, 2015 |
| First Submitted that Met QC Criteria : | October 14, 2015 |
| First Posted : | October 15, 2015 (Estimate) |
| Results First Submitted : | July 8, 2019 |
| Results First Submitted that Met QC Criteria : | July 8, 2019 |
| Results First Posted : | August 2, 2019 |
| Last Update Submitted that Met QC Criteria : | September 13, 2021 |
| Last Update Posted : | October 8, 2021 |